Detection of PCV1 Virus Caused Temporary Suspension of Rotarix Vaccine
Abstract:FDA is requiring the healthcare practitioners to temporarily stop using Rotarix vaccine, manufactured by GlaxoSmithKline (GSK) for rotavirus immunization in the US, as the FDA wishes to learn more about components of a superfluous virus detected in the vaccine. However, there is no evidence at this time that this finding poses a safety risk.
Compliance Trainings
Sterile Filtration of Pharmaceutical Products - Validation and Regulatory Requirements
By - Roger Cowan
On Demand Access Anytime
By - Roger Cowan
On Demand Access Anytime
HVAC and GMP Environmental Control - for Pharmaceutical Cleanrooms
By - Roger Cowan
Live December 10, 2024
By - Roger Cowan
Live December 10, 2024
Extractables and Leachables in Early Phase Development
By - Wayland Rushing
On Demand Access Anytime
By - Wayland Rushing
On Demand Access Anytime
Processes & Effects of Immunogenicity to Biologics & the Screening Methodologies - 3 hour Virtual Training
By - Gwen Wise Blackman
On Demand Access Anytime
By - Gwen Wise Blackman
On Demand Access Anytime
Compliance Standards
You Recently Viewed
